Press Releases

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Partnership for Drug-Free Kids has launched two campaigns that examine the impact of opioid addiction on families, while offering

WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Today, the Smarter Health Care Coalition, a multi-stakeholder coalition representing consumer organizations, employer groups, health plans, life science companies, provider-related organizations, academic centers, and foundations, advocated for the Secretary of Health and Human Services (HHS) to expand the scope of value-ba

BOONE, N.C., Aug. 21, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors.

GALVESTON, Texas, Aug. 21, 2019 /PRNewswire/ -- Chrysalis BioTherapeutics, Inc. today announced that the US Food and Drug Administration (FDA) Office of Orphan Product Development and the European Medicines Agency (EMA) have granted Orphan Drug Designation (ODD) to the company's lead compound, TP508 (rusalatide acetate) for the treatment of acute radiation syndrome

TOKYO and NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application

PARAMUS, N.J., Aug. 21, 2019 /PRNewswire/ -- Steve White, CEO of Harvest Health & Recreation, will deliver a Keynote Address, entitled: "Doing Well by Doing Good," at the 6th Annual

COLORADO SPRINGS, Colo., Aug. 21, 2019 /PRNewswire/ -- Break the Silence Against Domestic Violence's 2019 Angel Fund made the biggest impact yet. Bereaved families a

WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- The following statement was issued by Dan Stein, president of the Federation for American Immigration Reform (FAIR), in response to the announcement from the Department of Homeland Security and the Department of Health and Human Services on a final rule that will allow for the termin

The technology should reduce costs to patients and accelerate drug development   BEDFORD, Mass., Aug. 21, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the produc

BIRMINGHAM, Ala., Aug. 21, 2019 /PRNewswire/ -- Therapy Brands is excited to welcome Shannon Vann as the VP of Marketing. Vann joins the Therapy Bran